New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient

Susanna A. McColley, Jane Davies, Felix Ratjen, Manu Jain

Research output: Contribution to journalArticlepeer-review

Abstract

This educational activity is adapted from a live satellite symposium held during the 29th Annual North American Cystic Fibrosis Conference in Phoenix, Arizona (online access: http://www.elseviercme.com/cysticfibrosis/598e). This educational symposium will update clinicians on the changes in disease progression that are now seen in CFTR modulator-treated patients. With the recent scientific advancements and the principles of precision medicine, disease progression and quality of life are drastically improving for patients with cystic fibrosis. Current clinical trial data shows new and emerging therapeutic options that are beneficial to specific gene mutations. Expert faculty will present comprehensive case studies and conduct interactive panel discussions to enhance your knowledge in the advanced science of cystic fibrosis and patient management strategies.

Original languageEnglish (US)
Pages (from-to)e21
JournalJournal of Cystic Fibrosis
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2016

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient'. Together they form a unique fingerprint.

Cite this